Mirjacic-Martinovic Katarina M,Vuletic Ana M,Tisma-Miletic Nevena,Matkovic Suzana V,Gavrilovic Dusica,Ninkovic Aleksandra Z,Jurisic Vladimir B,Babovic Nada Lj (2024) Circulating IL-6 is associated with disease progression in BRAFwt metastatic melanoma patients receiving anti-PD-1 therapy, JOURNAL OF CLINICAL PATHOLOGY, vol. 77, br. 5, str. 343-351 (Article) 

Mirjacic-Martinovic Katarina M,Vuletic Ana M,Tisma-Miletic Nevena,Nedeljkovic Milica D,Babovic Nada Lj,Matkovic Suzana V,Jurisic Vladimir B (2023) Increased circulating monocyte MDSCs positively correlate with serum Interleukin-10 in metastatic melanoma patients, INNATE IMMUNITY, vol. 29, br. 3-4, str. 37-44 (Article) 

Mirjacic-Martinovic Katarina M,Vuletic Ana M,Malisic Emina J,Srdic-Rajic Tatjana V,Tisma-Miletic Nevena,Babovic Nada Lj,Jurisic Vladimir B (2022) Increased circulating TGF-beta 1 is associated with impairment in NK cell effector functions in metastatic melanoma patients, GROWTH FACTORS, vol. 40, br. 5-6, str. 231-239 (Article) 

Nikic Predrag Z,Babovic Nada Lj,Dzamic Zoran M,Salma Svetlana,Stojanovic Vesna,Matkovic Suzana V,Pejcic Zoran,Juskic Kristina,Soldatovic Ivan A (2022) Real World Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Only Available Sunitinib and Pazopanib in First-Line Setting, FRONTIERS IN ONCOLOGY, vol. 12, br. , str. - (Article) 

Vuletic Ana M,Konjevic Gordana M,Larsen Annette K,Babovic Nada Lj,Jurisic Vladimir B,Krivokuca Ana M,Mirjacic-Martinovic Katarina M (2020) Interleukin-4-induced natural killer cell antitumor activity in metastatic melanoma patients, EUROPEAN CYTOKINE NETWORK, vol. 31, br. 3, str. 104-112 (Article) 

Todorovic Vladimir,...,Babovic Nada Lj,...,Cetnikovic Bojana,Ceric Timur,...,Dzamic Zoran M,Dzodic Radan R,Eri Zivka,...,Knezevic-Usaj Slavica F,Kovcin Vladimir N,...,Markovic Ivan Z,Markovic Milan,Mijalkovic Nenad,...,Pantelic Aleksandra,Popovic Lazar S,Radosavljevic Davorin Z,...,Radulovic Sinisa S,...,Rosic Ivana,...,Stamatovic Ljiljana,...,Tesanovic Dusanka D,Tomasevic Zorica I,Tomasevic Zoran M,...,Vasovic Suzana,Vicko Ferenc,...,Zaric Bojan,...,(broj koautora 65) (2019) AROME-ESO Oncology Consensus Conference: access to cancer care innovations in countries with limited resources. Association of Radiotherapy and Oncology of the Mediterranean Area (AROME-Paris) and European School of Oncology (ESO - Milan), JOURNAL OF BUON, vol. 24, br. 5, str. 2180-2197 (Article) 

Kandolf-Sekulovic Lidija O,...,Babovic Nada Lj,...,(broj koautora 38) (2018) Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries, EUROPEAN JOURNAL OF CANCER, vol. 104, br. , str. 201-209 (Article) 

Konjevic Gordana M,Vuletic Ana M,Mirjacic-Martinovic Katarina M,Krivokuca Ana M,Jankovic Radmila N,Babovic Nada Lj (2017) Evaluation of the Functional Capacity of NK Cells of Melanoma Patients in an In Vitro Model of NK Cell Contact with K562 and FemX Tumor Cell Lines, JOURNAL OF MEMBRANE BIOLOGY, vol. 250, br. 5, str. 507-516 (Article) 

Mirjacic-Martinovic Katarina M,Vuletic Ana M,Babovic Nada Lj,Dzodic Radan R,Konjevic Gordana M,Jurisic Vladimir B (2017) Attenuated in vitro effects of IFN-alpha, IL-2 and IL-12 on functional and receptor characteristics of peripheral blood lymphocytes in metastatic melanoma patients, CYTOKINE, vol. 96, br. , str. 30-40 (Article) 

Kandolf-Sekulovic Lidija O,...,Babovic Nada Lj,...,(broj koautora 37) (2017) More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments, EUROPEAN JOURNAL OF CANCER, vol. 75, br. , str. 313-322 (Article) 

Mirjacic-Martinovic Katarina M,Babovic Nada Lj,Dzodic Radan R,Jurisic Vladimir B,Ninkovic Aleksandra Z,Konjevic Gordana M (2016) Beneficial in-vitro effects of interleukin-2, interleukin-12, and their combination on functional and receptor characteristics of natural killer cells in metastatic melanoma patients with normal serum lactate dehydrogenase levels, MELANOMA RESEARCH, vol. 26, br. 6, str. 551-564 (Article) 

Mirjacic-Martinovic Katarina M,Srdic Tatjana V,Babovic Nada Lj,Dzodic Radan R,Jurisic Vladimir B,Konjevic Gordana M (2016) Decreased expression of pSTAT, IRF-1 and DAP10 signalling molecules in peripheral blood lymphocytes of patients with metastatic melanoma, JOURNAL OF CLINICAL PATHOLOGY, vol. 69, br. 4, str. 300-306 (Article) 

Mirjacic-Martinovic Katarina M,Babovic Nada Lj,Dzodic Radan R,Jurisic Vladimir B,Matkovic Suzana V,Konjevic Gordana M (2015) Favorable in vitro effects of combined IL-12 and IL-18 treatment on NK cell cytotoxicity and CD25 receptor expression in metastatic melanoma patients, JOURNAL OF TRANSLATIONAL MEDICINE, vol. 13, br. , str. - (Article) 

Blay Jean-Yves,...,Babovic Nada Lj,...,(broj koautora 18) (2015) Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial, LANCET ONCOLOGY, vol. 16, br. 5, str. 531-540 (Article) 

Kandolf-Sekulovic Lidija O,Babovic Nada Lj,Jokic Neven,Balic Mirjana,Nikolin Borislava L,Nikolic Dejan V,Janjic Zlata M,Mijuskovic Zeljko P,Rajovic Milica I,Novakovic Marijan,Vrbic Svetislav,Pejcic Ivica,Kovacevic Predrag T,Mihajlovic Dragan,Roganovic Tatjana,Vicko Ferenc,Nikolic Jelena Ratko,Marinkovic Marija D,Bizetic Zorana (2015) Clinicopathological characteristics, diagnosis and treatment of melanoma in Serbia - the Melanoma Focus Study, VOJNOSANITETSKI PREGLED, vol. 72, br. 4, str. 312-316 (Article) 

Mirjacic-Martinovic Katarina M,Babovic Nada Lj,Dzodic Radan R,Jurisic Vladimir B,Tanic Nikola T,Konjevic Gordana M (2014) Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma patients, MELANOMA RESEARCH, vol. 24, br. 4, str. 295-304 (Article) 

Konjevic Gordana M,Mirjacic-Martinovic Katarina M,Vuletic Ana M,Babovic Nada Lj (2012) In vitro increased natural killer cell activity of metastatic melanoma patients with interferon-alpha alone as opposed to its combination with 13-cis retinoic acid is associated with modulation of NKG2D and CD161 activating receptor expression, JOURNAL OF BUON, vol. 17, br. 4, str. 761-769 (Article) 

Mirjacic-Martinovic Katarina M,Konjevic Gordana M,Babovic Nada Lj,Inic Momcilo M (2011) The Stage Dependent Changes in NK Cell Activity and the Expression of Activating and Inhibitory NK Cell Receptors in Melanoma Patients, JOURNAL OF SURGICAL RESEARCH, vol. 171, br. 2, str. 637-649 (Article) 

Konjevic Gordana M,Mirjacic-Martinovic Katarina M,Vuletic Ana M,Babovic Nada Lj (2010) In-vitro IL-2 or IFN-alpha-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients, MELANOMA RESEARCH, vol. 20, br. 6, str. 459-467 (Article) 

Konjevic Gordana M,Mirjacic-Martinovic Katarina M,Jurisic Vladimir B,Babovic Nada Lj,Spuzic Ivan (2009) Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: Decreased NKG2D and increased CD158a receptors on CD3-CD16+NK cells, BIOMARKERS, vol. 14, br. 4, str. 258-270 (Article) 

Bjelogrlic Snezana K,Radulovic Sinisa S,Babovic Nada Lj (2008) Molecular targeting agents in renal cell carcinoma: Present strategies and future perspectives, CURRENT PHARMACEUTICAL DESIGN, vol. 14, br. 11, str. 1058-1077 (Review) 

Konjevic Gordana M,Mirjacic-Martinovic Katarina M,Vuletic Ana M,Jovic Viktor,Jurisic Vladimir B,Babovic Nada Lj,Spuzic Ivan (2007) Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients, CLINICAL & EXPERIMENTAL METASTASIS, vol. 24, br. 1, str. 1-11 (Article) 

Juranic Zorica D,Stanojevic-Bakic Nevenka,Zizak Zeljko S,Babovic Nada Lj,Radovic-Kovacevic V,Stanojkovic Tatjana P,Dzodic Radan R (2003) Antimelanoma immunity in vitiligo and melanoma patients, NEOPLASMA, vol. 50, br. 4, str. 305-309 (Article) 

Jelic Svetislav B,Stamatovic Ljiljana,Vucicevic Slavko S,Petrovic Zeljko M,Kreacic Miroslav,Babovic Nada Lj,Jovanovic Natasa,Mikic Anton A,Gavrilovic Dusica (2002) Use of high-dose cytarabine to enhance cisplatin cytotoxicity - effects on the response and overall survival rates of advanced head and neck cancer patients, EUROPEAN JOURNAL OF CANCER, vol. 38, br. 11, str. 1478-1489 (Article) 

Jelic Svetislav B,Babovic Nada Lj,Kovcin Vladimir N,Milicevic N,Milanovic Nenad,Popov Ivan P,Radosavljevic Davorin Z (2002) Comparison of the efficacy of two different dosage dacarbazine-based regimens and two regimens without dacarbazine in metastatic melanoma: a single-centre randomized four-arm study, MELANOMA RESEARCH, vol. 12, br. 1, str. 91-98 (Article) 

Jelic Svetislav B,Babovic Nada Lj,Stamatovic Ljiljana,Kreacic Miroslav,Matkovic Suzana V,Popov Ivan P (2001) Vinblastin-carboplatin for metastatic cutaneous melanoma as first-line chemotherapy and in dacarbazine failures - A single-center study, MEDICAL ONCOLOGY, vol. 18, br. 3, str. 189-195 (Article) 

Jelic Svetislav B,Mitrovic LB,Radosavljevic Davorin Z,Elezar E,Babovic Nada Lj,Kovcin Vladimir N,Tomasevic Zorica I,Kovacevic S,Gavrilovic Dusica,Radulovic Sinisa S (2001) Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study, LUNG CANCER, vol. 34, br. 1, str. 1-13 (Article) 

Babovic Nada Lj,Jelic Svetislav B,Jovanovic V (2000) Primary non-Hodgkin lymphoma of the breast. Is it possible to avoid mastectomy?, JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, vol. 19, br. 2, str. 149-154 (Article) 

Jelic Svetislav B,Babovic Nada Lj,Kreacic Miroslav,Matkovic Suzana V,Milanovic Nenad,Gavrilovic Dusica,Tomasevic Zoran M (1999) Epirubicin 150 mg/m(2)-cisplatin versus epirubicin 180 mg/m(2)-cisplatin for advanced soft tissue sarcoma, INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, vol. 19, br. 4, str. 129-138 (Article)